Panbela Therapeutics (OTC:PBLA) Stock, Quote.Headers.trade-ideas

Panbela Therapeutics

Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.

Long Ideas

News

Penny Stocks

Pre-Market Outlook

Markets

Trading Ideas

ALPS ETF Trusthen & Steers Global Realty Majors ETF

PBLA

SINT

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 4 Health Care Stocks That Are Preparing To Pump This Month

laboratory-563423_1920

Equities

Movers

General

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds.

What&#39;s Going On With Panbela Therapeutics Stock Today?

Earnings

Eurozone

Commodities

Global

Intraday Update

BFRG

CDLX

SNCE

SOFI

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday.

The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to 15,529.84. The S&amp;P 500 also rose, gaining, 0.19% to 4,900.27.

Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc.

Panbela Therapeutics Inc

AREN

The Arena Group Plan To Regain NYSE Compliance Accepted

LAES

SEALSQ Receives Formal Written Confirmation From Nasdaq Confirming That It Has Regained Compliance With Minimum Bid Price Requirement

<h3>Gainers</h3>
<ul>
<li><strong>Kore Group Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NYSE">KORE</a>) stock increased by 14.9% to $2.16 during Thursday's pre-market session. The market value of their outstanding shares is at $36.7 million. </li>
<li><strong>Zedge</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZDGE#AMEX">ZDGE</a>) stock rose 10.89% to $2.95. The company's market cap stands at $41.7 million. </li>
<li><strong>Gaxos.AI</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GXAI#NASDAQ">GXAI</a>) shares moved upwards by 9.8% to $2.8. The company's market cap stands at $10.3 million. </li>
<li><strong>Asset Entities</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) shares rose 8.36% to $0.48. The company's market cap stands at $4.2 million. </li>
<li><strong>Shenandoah</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHEN#NASDAQ">SHEN</a>) stock rose 7.47% to $13.8. The company's market cap stands at $753.5 million. </li>
<li><strong>FingerMotion</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNGR#NASDAQ">FNGR</a>) shares rose 7.27% to $1.18. The company's market cap stands at $67.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Baosheng Media Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) shares decreased by 26.1% to $5.25 during Thursday's pre-market session. The company's market cap stands at $8.0 million. </li>
<li><strong>Brera Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BREA#NASDAQ">BREA</a>) stock decreased by 20.0% to $0.8. The market value of their outstanding shares is at $10.6 million. </li>
<li><strong>Direct Digital Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) stock fell 16.72% to $3.09. The company's market cap stands at $46.6 million. </li>
<li><strong>Treasure Global</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock fell 8.18% to $0.21. The market value of their outstanding shares is at $2.2 million. </li>
<li><strong>Onfolio Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONFO#NASDAQ">ONFO</a>) stock decreased by 6.67% to $1.26. The company's market cap stands at $6.4 million. </li>
<li><strong>VS Media Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) stock fell 6.62% to $1.13. The market value of their outstanding shares is at $3.6 million. The company's, H1 earnings came out 3 days ago.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ASST

BAOS

BREA

DRCT

FNGR

GXAI

KORE

ONFO

SHEN

VSME

ZDGE

12 Communication Services Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>Coeptis Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) shares rose 118.1% to $0.31 during Thursday's pre-market session. The market value of their outstanding shares is at $12.7 million. </li>
<li><strong>Adagio Medical Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADGM#NASDAQ">ADGM</a>) stock moved upwards by 24.67% to $1.21. The market value of their outstanding shares is at $17.5 million. </li>
<li><strong>China SXT Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares rose 23.07% to $0.48. The company's market cap stands at $1.9 million. </li>
<li><strong>TScan Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) stock rose 15.46% to $3.36. The market value of their outstanding shares is at $179.3 million. </li>
<li><strong>RAPT Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock increased by 12.71% to $1.95. The market value of their outstanding shares is at $68.1 million. </li>
<li><strong>Revelation Biosciences</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REVB#NASDAQ">REVB</a>) stock rose 12.64% to $0.34. The company's market cap stands at $2.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Anebulo Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANEB#NASDAQ">ANEB</a>) stock fell 23.5% to $1.24 during Thursday's pre-market session. The market value of their outstanding shares is at $50.9 million. </li>
<li><strong>Tivic Health Systems</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock declined by 18.23% to $0.3. The company's market cap stands at $2.5 million. </li>
<li><strong>180 Life Sciences</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) stock decreased by 16.56% to $2.42. The company's market cap stands at $4.7 million. </li>
<li><strong>Carmell</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock decreased by 15.71% to $0.24. The company's market cap stands at $5.0 million. </li>
<li><strong>Theriva Biologics</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) shares fell 14.78% to $1.5. The company's market cap stands at $4.1 million. </li>
<li><strong>NeuroPace</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) stock decreased by 10.6% to $9.96. The company's market cap stands at $297.2 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ADGM

ANEB

ATNF

COEP

CTCX

NPCE

RAPT

REVB

SXTC

TCRX

TIVC

TOVX

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>Zoomcar Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares rose 104.2% to $2.92 during Thursday's pre-market session. The market value of their outstanding shares is at $6.4 million. </li>
<li><strong>SES AI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares moved upwards by 39.45% to $0.99. The company's market cap stands at $354.0 million. </li>
<li><strong>Palladyne AI</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) stock moved upwards by 36.23% to $6.73. The market value of their outstanding shares is at $202.6 million. </li>
<li><strong>Lichen China</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) stock increased by 34.31% to $0.28. The company's market cap stands at $13.5 million. </li>
<li><strong>China Yuchai Intl</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYD#NYSE">CYD</a>) shares moved upwards by 31.76% to $12.9. The company's market cap stands at $483.9 million. </li>
<li><strong>Zeo Energy</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) stock moved upwards by 17.75% to $2.52. The market value of their outstanding shares is at $34.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Jet AI</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock decreased by 13.2% to $5.32 during Thursday's pre-market session. The company's market cap stands at $6.9 million. </li>
<li><strong>CEA Industries</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEAD#NASDAQ">CEAD</a>) shares fell 11.81% to $7.1. The market value of their outstanding shares is at $5.6 million. </li>
<li><strong>Perma-Pipe Inlt Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPIH#NASDAQ">PPIH</a>) stock decreased by 11.54% to $14.5. The market value of their outstanding shares is at $115.7 million. As per the news, the Q3 earnings report came out 3 days ago. </li>
<li><strong>Graphjet Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock decreased by 11.33% to $0.54. The company's market cap stands at $79.3 million. </li>
<li><strong>Nocera</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCRA#NASDAQ">NCRA</a>) shares decreased by 10.5% to $0.91. The market value of their outstanding shares is at $12.7 million. </li>
<li><strong>Mobile Infrastructure</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) shares fell 7.31% to $4.19. The company's market cap stands at $178.0 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Mobile Infrastructure Corporation Common Stock

BEEP

CEA INDUSTRIES INC by CEA Industries Inc.

CEAD

JTAI

LICN

NCRA

PDYN

PPIH

ZCAR

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>SMX (Security Matters)</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares increased by 63.4% to $0.36 during Thursday's pre-market session. The company's market cap stands at $1.0 million. </li>
<li><strong>Castellum</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) shares moved upwards by 39.81% to $0.81. The market value of their outstanding shares is at $45.4 million. </li>
<li><strong>ReAlpha Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock moved upwards by 38.68% to $1.9. The company's market cap stands at $87.1 million. </li>
<li><strong>Sobr Safe</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock rose 18.94% to $1.13. The market value of their outstanding shares is at $1.0 million. </li>
<li><strong>XIAO-I</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) shares increased by 14.33% to $6.0. The company's market cap stands at $57.8 million. </li>
<li><strong>Kingsoft Cloud Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) stock rose 13.56% to $10.13. The company's market cap stands at $2.4 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Saverone 2014</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares declined by 30.4% to $1.1 during Thursday's pre-market session. The company's market cap stands at $3.0 million. </li>
<li><strong>Nvni Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) stock fell 10.44% to $5.15. The company's market cap stands at $147.4 million. As per the news, the FY earnings report came out today. </li>
<li><strong>AmpliTech Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) stock fell 8.17% to $3.71. The market value of their outstanding shares is at $57.7 million. </li>
<li><strong>WISeKey Intl Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) stock declined by 7.68% to $9.14. The company's market cap stands at $88.5 million. </li>
<li><strong>CommScope Hldg Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) stock decreased by 6.97% to $5.34. The company's market cap stands at $1.1 billion. </li>
<li><strong>Zepp Health</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) stock decreased by 6.05% to $2.8. The market value of their outstanding shares is at $167.9 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AIRE

AIXI

AMPG

COMM

NVNI

SOBR

SVRE

WKEY

ZEPP

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Dividends

PFBC

Preferred Bank Increases Dividend From $0.70 To $0.75/Share

WIIM

EVAX

Evaxion shares are trading higher after the company filed an application for a patent for vaccines targeting neisseria gonorrhoeae.

<p>The Merger Agreement was terminated by the mutual written consent of MRMC and MMLP. MMLP will continue to operate as a standalone publicly traded company.</p>


MMLP

Martin Midstream Partners Reports Termination Of Previously Announced Agreement And Plan Of Merger With Martin Resource Management

Management

First Hawaiian COO Christopher Dods To Resign In March 2025

AEHR

ALAB

ALLT

APPS

ARQQ

ATGL

ATOM

BBAI

BLIN

BNAI

CCTG

CMBM

CXAI

DATS

DUOT

EGAN

GRRR

HTCR

IDAI

IFBD

INTZ

IVDA

KOPN

LDTC

LIDR

LUNA

MLGO

MOBBW

MVIS

ONDS

PHUN

PONY

PRSO

QMCO

QUIK

RCAT

REKR

SKYT

SMSI

SOUN

TOYO

TSSI

VERI

VNET

VRME

VUZI

WISA

WRAP

Shares of tech-related stocks are trading higher. The sector may be gaining ahead of the new year.

<p>https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/20240424079?requestT[…]jMmM0OTkwMS0xYjJkLTRkMDUtYTNhNy0yZjU1YzU4MzA1NjEiLCJleHAiOjB9</p>


Biotech

Evaxion Biotech Files Application For Patent For Vaccines Targeting Neisseria Gonnorhoeae

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Trump Media &amp; Technology</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DJT, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 24 uncommon options trades for Trump Media &amp; Technology.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 58% bullish and 16%, bearish.</p>
<p>Out of all of the special options we uncovered, 8 are puts, for a total amount of $357,300, and 16 are calls, for a total amount of $573,060.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $67.0 for Trump Media &amp; Technology over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Trump Media &amp; Technology's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Trump Media &amp; Technology's whale activity within a strike price range from $20.0 to $67.0 in the last 30 days. </p>
<h3>Trump Media &amp; Technology Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245931_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DJT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$1.83</td>
<td>$1.55</td>
<td>$1.55</td>
<td>$31.00</td>
<td>$77.5K</td>
<td>46</td>
<td align="right">500</td>
</tr>
<tr>
<td>DJT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$16.45</td>
<td>$15.35</td>
<td>$15.5</td>
<td>$40.00</td>
<td>$71.3K</td>
<td>29</td>
<td align="right">48</td>
</tr>
<tr>
<td>DJT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$21.7</td>
<td>$19.55</td>
<td>$21.7</td>
<td>$20.00</td>
<td>$52.0K</td>
<td>327</td>
<td align="right">0</td>
</tr>
<tr>
<td>DJT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$40.00</td>
<td>$51.5K</td>
<td>3.3K</td>
<td align="right">129</td>
</tr>
<tr>
<td>DJT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/10/25</td>
<td>$2.54</td>
<td>$2.36</td>
<td>$2.36</td>
<td>$37.00</td>
<td>$47.2K</td>
<td>76</td>
<td align="right">627</td>
</tr>
</tbody>
</table>
</p>
<h3>About Trump Media &amp; Technology</h3>
<p>Trump Media &amp; Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest global conversation without discriminating against political ideology.</p>
<p>In light of the recent options history for Trump Media &amp; Technology, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Trump Media &amp; Technology Standing Right Now?</h3>
<ul>
<li>With a trading volume of 6,474,777, the price of DJT is up by 3.73%, reaching $37.13.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 39 days from now.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Trump Media &amp; Technology with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

This Is What Whales Are Betting On Trump Media & Technology

<p>Financial giants have made a conspicuous bearish move on POET Technologies. Our analysis of options history for POET Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POET#NASDAQ">POET</a>) revealed 54 unusual trades.</p>
<p>Delving into the details, we found 9% of traders were bullish, while 74% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $219,512, and 50 were calls, valued at $2,702,382.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $3.0 to $11.0 for POET Technologies during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for POET Technologies options trades today is 4353.52 with a total volume of 144,184.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for POET Technologies's big money trades within a strike price range of $3.0 to $11.0 over the last 30 days.</p>
<h3>POET Technologies Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245926_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>POET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$0.9</td>
<td>$0.8</td>
<td>$0.8</td>
<td>$8.00</td>
<td>$160.2K</td>
<td>1.8K</td>
<td>2.3K</td>
</tr>
<tr>
<td>POET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.75</td>
<td>$1.55</td>
<td>$1.55</td>
<td>$7.00</td>
<td>$155.1K</td>
<td>2.7K</td>
<td>1.3K</td>
</tr>
<tr>
<td>POET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$1.5</td>
<td>$1.25</td>
<td>$1.5</td>
<td>$10.00</td>
<td>$150.0K</td>
<td>10.1K</td>
<td>2.2K</td>
</tr>
<tr>
<td>POET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.5</td>
<td>$1.4</td>
<td>$1.4</td>
<td>$10.00</td>
<td>$131.4K</td>
<td>10.1K</td>
<td>4.3K</td>
</tr>
<tr>
<td>POET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.2</td>
<td>$1.1</td>
<td>$1.1</td>
<td>$10.00</td>
<td>$110.0K</td>
<td>8.2K</td>
<td>1.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About POET Technologies</h3>
<p>POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.</p>
<p>Having examined the options trading patterns of POET Technologies, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of POET Technologies</h3>
<ul>
<li>Trading volume stands at 10,474,973, with POET's price up by 34.81%, positioned at $7.76.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 78 days.</li>
</ul>
<h3>What The Experts Say On POET Technologies</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $7.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Northland Capital Markets downgraded its action to Outperform with a price target of $7. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest POET Technologies options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


POET

Check Out What Whales Are Doing With POET

<p>Deep-pocketed investors have adopted a bearish approach towards Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MSFT usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 130 extraordinary options activities for Microsoft. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 36% leaning bullish and 42% bearish. Among these notable options, 26 are puts, totaling $3,116,741, and 104 are calls, amounting to $10,122,094.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $660.0 for Microsoft, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Microsoft's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Microsoft's substantial trades, within a strike price spectrum from $110.0 to $660.0 over the preceding 30 days.</p>
<h3>Microsoft Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245921_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$51.05</td>
<td>$49.8</td>
<td>$49.8</td>
<td>$510.00</td>
<td>$747.0K</td>
<td>166</td>
<td>150</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$70.2</td>
<td>$68.1</td>
<td>$69.35</td>
<td>$460.00</td>
<td>$554.8K</td>
<td>552</td>
<td>81</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$30.05</td>
<td>$29.6</td>
<td>$29.6</td>
<td>$420.00</td>
<td>$444.0K</td>
<td>5.8K</td>
<td>155</td>
</tr>
<tr>
<td>MSFT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/03/25</td>
<td>$11.65</td>
<td>$11.2</td>
<td>$11.4</td>
<td>$450.00</td>
<td>$432.0K</td>
<td>759</td>
<td>399</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$10.9</td>
<td>$10.85</td>
<td>$10.9</td>
<td>$435.00</td>
<td>$327.0K</td>
<td>8.4K</td>
<td>1.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Microsoft</h3>
<p>Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).</p>
<p>After a thorough review of the options trading surrounding Microsoft, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Microsoft Standing Right Now?</h3>
<ul>
<li>With a trading volume of 5,155,601, the price of MSFT is up by 0.05%, reaching $439.55.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 33 days from now.</li>
</ul>
<h3>Expert Opinions on Microsoft</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $525.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho persists with their Outperform rating on Microsoft, maintaining a target price of $510.<br />
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Microsoft, which currently sits at a price target of $515.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Microsoft with a target price of $525.<br />
&#x2A; An analyst from Loop Capital has decided to maintain their Buy rating on Microsoft, which currently sits at a price target of $550. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Microsoft with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


MSFT

Microsoft's Options Frenzy: What You Need to Know

<p>Financial giants have made a conspicuous bullish move on Freeport-McMoRan. Our analysis of options history for Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) revealed 11 unusual trades.</p>
<p>Delving into the details, we found 54% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $213,113, and 7 were calls, valued at $287,434.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $42.0 for Freeport-McMoRan over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Freeport-McMoRan's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Freeport-McMoRan's substantial trades, within a strike price spectrum from $30.0 to $42.0 over the preceding 30 days.</p>
<h3>Freeport-McMoRan Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245040_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$0.62</td>
<td>$0.59</td>
<td>$0.61</td>
<td>$30.00</td>
<td>$73.2K</td>
<td>68</td>
<td>1.3K</td>
</tr>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$0.34</td>
<td>$0.31</td>
<td>$0.34</td>
<td>$42.00</td>
<td>$68.0K</td>
<td>7.3K</td>
<td>2.0K</td>
</tr>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.95</td>
<td>$3.85</td>
<td>$3.9</td>
<td>$40.00</td>
<td>$61.2K</td>
<td>1.2K</td>
<td>259</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.68</td>
<td>$2.66</td>
<td>$2.66</td>
<td>$40.00</td>
<td>$50.2K</td>
<td>4.3K</td>
<td>189</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.3</td>
<td>$5.25</td>
<td>$5.29</td>
<td>$42.00</td>
<td>$50.2K</td>
<td>7.4K</td>
<td>96</td>
</tr>
</tbody>
</table>
</p>
<h3>About Freeport-McMoRan</h3>
<p>Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2023, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. About 75% of 2023 revenue was from copper, with a further 15% from gold and about 10% from molybdenum. It had about 25 years of copper reserves at end December 2023. we expect it to sell similar amounts of copper midcycle in 2028, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.</p>
<h3>Where Is Freeport-McMoRan Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 4,177,817, with FCX's price down by -0.25%, positioned at $39.12.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 27 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Freeport-McMoRan options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Freeport-McMoRan Unusual Options Activity For December 26

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>CME Gr</strong>.</p>
<p>Looking at options history for CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) we detected 21 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 19% with bearish.</p>
<p>From the overall spotted trades, 11 are puts, for a total amount of $2,422,975 and 10, calls, for a total amount of $602,430.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $300.0 for CME Gr over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for CME Gr's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CME Gr's whale activity within a strike price range from $85.0 to $300.0 in the last 30 days. </p>
<h3>CME Gr Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245035_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$68.4</td>
<td>$65.0</td>
<td>$66.5</td>
<td>$300.00</td>
<td>$1.9M</td>
<td align="right">0</td>
<td align="right">300</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$154.1</td>
<td>$152.5</td>
<td>$154.1</td>
<td>$85.00</td>
<td>$154.1K</td>
<td align="right">5</td>
<td align="right">30</td>
</tr>
<tr>
<td>CME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$16.8</td>
<td>$16.4</td>
<td>$16.55</td>
<td>$250.00</td>
<td>$87.7K</td>
<td align="right">7</td>
<td align="right">81</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$139.1</td>
<td>$137.7</td>
<td>$139.1</td>
<td>$100.00</td>
<td>$69.5K</td>
<td align="right">3</td>
<td align="right">30</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$140.3</td>
<td>$137.7</td>
<td>$139.1</td>
<td>$100.00</td>
<td>$69.5K</td>
<td align="right">3</td>
<td align="right">25</td>
</tr>
</tbody>
</table>
</p>
<h3>About CME Gr</h3>
<p>Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.</p>
<p>Having examined the options trading patterns of CME Gr, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is CME Gr Standing Right Now?</h3>
<ul>
<li>With a volume of 514,277, the price of CME is down -0.14% at $239.13. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for CME Gr</h3>
<p>A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $258.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on CME Gr, maintaining a target price of $257.<br />
&#x2A; An analyst from Keefe, Bruyette &amp; Woods persists with their Market Perform rating on CME Gr, maintaining a target price of $260. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CME Gr, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


What the Options Market Tells Us About CME Gr

<p>Financial giants have made a conspicuous bearish move on Chevron. Our analysis of options history for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) revealed 10 unusual trades.</p>
<p>Delving into the details, we found 20% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $173,100, and 7 were calls, valued at $362,356.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $170.0 for Chevron over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Chevron's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chevron's whale trades within a strike price range from $75.0 to $170.0 in the last 30 days. </p>
<h3>Chevron Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735245029_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.99</td>
<td>$2.87</td>
<td>$2.99</td>
<td>$145.00</td>
<td>$119.6K</td>
<td>9.1K</td>
<td align="right">434</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.25</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$170.00</td>
<td>$93.0K</td>
<td>640</td>
<td align="right">229</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$70.4</td>
<td>$68.55</td>
<td>$69.43</td>
<td>$75.00</td>
<td>$69.4K</td>
<td>21</td>
<td align="right">12</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$45.4</td>
<td>$44.05</td>
<td>$44.64</td>
<td>$100.00</td>
<td>$53.5K</td>
<td>20</td>
<td align="right">12</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$15.6</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$130.00</td>
<td>$47.7K</td>
<td>8</td>
<td align="right">45</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chevron</h3>
<p>Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.</p>
<p>In light of the recent options history for Chevron, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Chevron</h3>
<ul>
<li>With a volume of 2,747,664, the price of CVX is down -0.21% at $143.54. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
<h3>What The Experts Say On Chevron</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $179.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Chevron, targeting a price of $188.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on Chevron, which currently sits at a price target of $160.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Chevron, targeting a price of $195.<br />
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Chevron, which currently sits at a price target of $173. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chevron options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


What the Options Market Tells Us About Chevron

<p>There&#8217;s something magical about moving into a newly constructed home: the smell of recently milled wood, new paint and gleaming tiles – knowing no one has lived there before you. However, like anything in real estate, that privilege comes with a price. According to a recent report from <a href="https://www.benzinga.com/real-estate/24/11/42234719/redfin-reveals-22-of-renters-say-they-have-nothing-left-after-paying-rent">Redfin</a>, asking rents for newly constructed apartments rose 1.5% – the biggest year-over-year increase in 18 months – to a median of $1,802 in the third quarter.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"><strong> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</strong></a></strong></li>
<li><strong>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/go/arrived-private-credit-yf"><strong>7-9% target yield with monthly dividends would you invest in it</strong></a>?</strong></li>
</ul>
<p>It&#8217;s a surprising stat given that the deluge of newly constructed apartments, primarily in Sunbelt states, caused rents for new apartments to fall by more than 7% in Q1 and Q2. The latest numbers reflect that the newer apartments are now being filled. Redfin based its numbers on an analysis of the U.S. Census Bureau&#8217;s data for newly constructed, unfurnished, unsubsidized, privately financed rental apartments in buildings with five or more units. Apartments completed in the second quarter of 2024 and either rented or not rented within three months were used to compile the survey.</p>
<h2 class="wp-block-heading">The Northeast Stumbles While Everywhere Else Soars</h2>
<p>Only the Northeast saw asking rents fall (-3.6%) after the number of recently finished apartments rose 13% year over year in the second quarter to the highest level since the fourth quarter of 2022. The rental decrease could have been due to several reasons – primarily that rents in the Northeast, particularly in places like Boston and <a href="https://www.benzinga.com/real-estate/24/12/42256888/as-nyc-rents-hit-new-highs-85-of-residents-look-to-buy-elsewhere-heres-what-they-find">New York</a>, were already high, with many residents moving to the Sunbelt states, according to government census data.&nbsp;</p>
<p><strong>See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks-y2"><strong>this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</strong></a></strong></p>
<p>&#8220;We would usually predict that rents will stay flat or even potentially fall when there are so many new apartment buildings opening up. What&#8217;s interesting in the third quarter is that rents are rising by more than the national average in the West and Midwest, even after the number of new apartments spiked between 30-50%,&#8221; Redfin Senior Economist Sheharyar Bokhari said in the report. &#8220;This is likely due to more new apartments being built in more expensive metros in each region, pushing the overall levels up.&#8221;</p>
<h2 class="wp-block-heading">High-End Finishes and Amenities</h2>
<p>The competition among new multifamily developments for tenants has led to higher-end finishes and more amenities, even among mid-priced rentals. Comfort, sustainability and catering to the increased number of work-from-home or hybrid working tenants have been at the forefront of developers&#8217; minds.</p>
<p><strong>Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"><strong> you can become an investor for $0.80 per share today.</strong></a></strong></p>
<p>&#8220;From state-of-the-art fitness facilities to luxurious pools, <a href="https://www.benzinga.com/markets/24/08/40168219/despite-market-challenges-multifamily-real-estate-shines-50-of-our-loans-this-year-says-industry-exp">multifamily developments</a> can bring a unique experience to day-to-day life,&#8221; Jared Bradley, president and founder of The Bradley Projects, told<a href="https://www.multifamilyexecutive.com/design-development/design/10-top-multifamily-design-trends-for-2024_o"> </a>multifamilyexecutive.com. &#8220;Small pockets of privacy for tenants to complete their work gives residents the feeling of &#8216;leaving their apartment&#8217; without stepping outside the building,&#8221; he added. &#8220;The confines of apartments can sometimes feel tight for working from home and areas designated for remote workers can allow tenants to leave their units and work from other comfortable places in their building.&#8221;</p>
<h2 class="wp-block-heading">More Of The Same In 2025</h2>
<p>According to<a href="https://www.yardimatrix.com/publications/download/file/6638-MatrixMultifamilyNationalReport-Winter2025?signup=false"> </a>a new outlook from Yardi Matrix, rents for new developments will continue to grow in 2025, outstripping other sectors of the multifamily sector. The report stated that a &#8220;large number of properties under construction will support robust supply growth again in 2025 … which will push rents higher as the supply boom starts to fade.&#8221;</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>The<a href="https://www.benzinga.com/go/equitymultiple-yf"><strong> Ascent Income Fund</strong></a> from EquityMultiple targets stable income from senior commercial real estate debt positions and has a historical distribution yield of 12.1% backed by real assets.<a href="https://www.benzinga.com/go/equitymultiple-yf"><strong> Earn a 1% return boost on your first EquityMultiple investment when you sign up here (accredited investors only)</strong></a>.</strong></li>
<li><strong>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100"><strong>become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</strong></a></strong></li>
</ul>


Dreaming Of Moving Into A Newly Constructed Apartment? Redfin Reports The Shocking Premium For That Privilege As Rents Soar

<p><strong>Palladyne AI Corp. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares are trading higher on possible continued momentum Thursday. The company announced that it completed the first autonomous tracking flight using its <a href="https://www.benzinga.com/pressreleases/24/12/b42647049/palladyne-ai-achieves-key-milestone-with-first-small-drone-autonomous-tracking-flight">Palladyne Pilot AI software platform</a> on Monday.</p>
<p><strong>What To Know: </strong>The test involved a third-party small drone that identified, prioritized and autonomously tracked terrestrial targets. This marked the first time Palladyne's AI platform interfaced with third-party autopilot software, enabling the drone to autonomously navigate while following a target.</p>
<p>Previously, the AI system demonstrated target identification and prioritization on stationary nodes and hovering drones. This new test flight expands the platform&#8217;s capabilities and moves it closer to commercialization, expected by the end of first-quarter 2025.</p>
<p>&#8220;Once we complete commercialization of Palladyne Pilot &#8212; which we expect to happen by the end of the&nbsp;first quarter&nbsp;of 2025 &#8212; small, economical drones will finally offer some of the same intelligence capabilities that larger, multi-million-dollar unmanned systems have had for years,&#8221; said <strong>Dr. Denis Garagic</strong>, co-founder and CTO, Palladyne AI.</p>
<p><strong>PDYN Price Action:</strong> Palladyne shares were up 44.7% at $7.15 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="513" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-1024x513.png" alt="" class="wp-image-707848" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-1024x513.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-768x385.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32-1536x770.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26104735/Screenshot-2024-12-26-at-10.46.32.png 1912w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42687003/kemper-to-rally-more-than-25-here-are-4-top-analyst-forecasts-for-thursday">Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday</a></strong></li>
</ul>
<p><em>Image Via Shutterstock.</em></p>


Palladyne AI Shares Are Surging Today: What you Need To know

Panbela Therapeutics, Inc. (PBLA) Q1 2024 Earnings Call Transcript

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Panbela Therapeutics</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pbla-stock-quote/"><strong>PBLA</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Panbela Therapeutics reported earnings per share of -$2.28. This was below the analyst estimate for EPS of -$1.48.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/pbla-stock-earnings-panbela-therapeutics-for-q1-of-2024/">PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024

Panbela Therapeutics, Inc. (PBLA) has disclosed a new risk, in the Regulation category. Panbela Therapeutics, Inc. faces a significant business ris...

Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Hold rating on Panbela Therapeutics (PBLA – Research Report). The co...

H.C. Wainwright Reaffirms Their Hold Rating on Panbela Therapeutics (PBLA)

Panbela Therapeutics GAAP EPS of -$1.47 beats by $0.60

Panbela Therapeutics, Inc. (PBLA) Q2 2024 Earnings Call Transcript

H.C. Wainwright analyst Joseph Pantginis maintained a Hold rating on Panbela Therapeutics (PBLA – Research Report) today. The company's shares clos...

H.C. Wainwright Remains a Hold on Panbela Therapeutics (PBLA)

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Panbela Therapeutics</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pbla-stock-quote/"><strong>PBLA</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Panbela Therapeutics reported earnings per share of -$1.47. This was above the analyst estimate for EPS of -$1.69.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/pbla-stock-earnings-panbela-therapeutics-for-q2-of-2024/">PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024

Panbela Therapeutics GAAP EPS of -$1.48

Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call Transcript

Press Releases

Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024

Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac

Panbela Provides Business Update and Reports Q1 2024 Financial Results

Panbela Announces Oral Presentation at Digestive Disease Week (DDW):

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification

Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024

Panbela Provides Business Update and Reports Q2 2024 Financial Results

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center

Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024

Panbela Provides Business Update and Reports Q3 2024 Financial Results

Roth MKM

Maxim Group

Roth Capital

Comments

Panbela Therapeutics

Panbela Therapeutics (PBLA) Forecast

Panbela Therapeutics (OTC:PBLA) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga